PTAB Rightly Axed Alcon Eye Drop Patent, Fed. Circ. Says
The Federal Circuit on Wednesday affirmed the Patent Trial and Appeal Board's decision to invalidate several claims in a patent covering Alcon Laboratories' Durezol eye drops, shooting down an appeal from...To view the full article, register now.
Already a subscriber? Click here to view full article